A TOR-targeting cancer drug unexpectedly extends yeast lifespan through a newly discovered metabolic feedback loop.
A next-generation drug tested in yeast was found to extend lifespan and slow aging by influencing a major growth-control pathway. Researchers also uncovered an unexpected role for agmatinases, enzymes ...
Researchers from the Centro Nacional de Investigaciones Oncológicas aimed to identify pathways that contribute to the metabolic reprogramming ability of cancer cells upon resistance to ...
Hosted on MSN
Inhibitor blocks flesh-eating bacteria's metabolism, reducing tissue damage in infections
A new study published in Nature Communications reveals a novel approach to mitigating tissue damage caused by Streptococcus pyogenes, the flesh-eating bacterium responsible for severe infections such ...
Researchers from Queen Mary University of London's School of Biological and Behavioural Sciences, using the simple fission yeast as a model, have shown that new TOR inhibitor rapalink-1 prolongs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback